{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:05:15Z","timestamp":1792033515660,"version":"4.4.0"},"reference-count":96,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Technology","doi-asserted-by":"publisher","award":["09SYN-14-643, MIS 450598"],"award-info":[{"award-number":["09SYN-14-643, MIS 450598"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00684","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T04:11:05Z","timestamp":1497327065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFN\u03b3-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis"],"prefix":"10.3389","volume":"8","author":[{"given":"Evita","family":"Athanasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Agallou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Tastsoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kammona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemis","family":"Hatzigeorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costas","family":"Kiparissides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evdokia","family":"Karagouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,13]]},"reference":[{"key":"B1","unstructured":"Visceral Leishmaniasis: Control Strategies and Epidemiological Situation Update in East Africa, Report of a WHO Bi-Regional Consultation Addis Ababa, Ethiopia2015"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"WHO leishmaniasis control team leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin Epidemiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit Vectors"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","article-title":"CD8+ T cells in Leishmania infections: friends or foes?","volume":"3","author":"St\u00e4ger","year":"2012","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"234fs18","DOI":"10.1126\/scitranslmed.3009118","article-title":"Using humans to make a human leishmaniasis vaccine","volume":"6","author":"Kamhawi","year":"2014","journal-title":"Sci Transl Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1093\/bioinformatics\/btm471","article-title":"Modeling the adaptive immune system: predictions and simulations","volume":"23","author":"Lundegaard","year":"2007","journal-title":"Bioinformatics"},{"key":"B9","doi-asserted-by":"publisher","first-page":"120139","DOI":"10.1098\/rsob.120139","article-title":"T-cell epitope vaccine design by immunoinformatics","volume":"3","author":"Patronov","year":"2013","journal-title":"Open Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2016.00467","article-title":"Post-genomics and vaccine improvement for Leishmania","volume":"7","author":"Seyed","year":"2016","journal-title":"Front Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/erv.09.160","article-title":"Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists","volume":"9","author":"Black","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"B13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1586\/erv.10.164","article-title":"Induction of anti-tumor immunity and T-cell responses using nanodelivery systems engrafting TLR-5 ligand","volume":"10","author":"Panda","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jconrel.2012.05.010","article-title":"Targeting tumor antigens to dendritic cells using particulate carriers","volume":"161","author":"Joshi","year":"2012","journal-title":"J Control Release"},{"key":"B15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2016.02.018","article-title":"Synthetic long peptide-based vaccine formulations for induction of cell mediated immunity: a comparative study of cationic liposomes and PLGA nanoparticles","volume":"226","author":"Varypataki","year":"2016","journal-title":"J Control Release"},{"key":"B16","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1016\/j.vaccine.2010.09.077","article-title":"Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: cross presentation and T cell activation","volume":"28","author":"Hirosue","year":"2010","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/vaccines3030638","article-title":"Small wonders \u2013 the use of nanoparticles for delivering antigen","volume":"3","author":"Taki","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2011","journal-title":"J Control Release"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","article-title":"PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity","volume":"12","author":"Silva","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00436-010-2176-4","article-title":"Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN","volume":"108","author":"Tafaghodi","year":"2011","journal-title":"Parasitol Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2147\/IJN.S30093","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.2217\/Nnm.12.74","article-title":"Characterization and evaluation of BNIPDaoct-loaded PLGA nanoparticles for visceral leishmaniasis: in vitro and in vivo studies","volume":"7","author":"Lima","year":"2012","journal-title":"Nanomedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.14573\/altex.1311041","article-title":"A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicity","volume":"31","author":"Etna","year":"2014","journal-title":"ALTEX"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0125228","DOI":"10.1371\/journal.pone.0125228","article-title":"Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo","volume":"10","author":"Stoel","year":"2015","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1038\/ncomms6283","article-title":"Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines","volume":"5","author":"Banchereau","year":"2014","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1016\/j.vaccine.2015.03.075","article-title":"Molecular signatures for vaccine development","volume":"33","author":"Maertzdorf","year":"2015","journal-title":"Vaccine"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e86306","DOI":"10.1371\/journal.pone.0086306","article-title":"Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E494","DOI":"10.3390\/ijms18030494","article-title":"Distinct antigen delivery systems induce dendritic cells\u2019 divergent transcriptional response: new insights from a comparative and reproducible computational analysis","volume":"18","author":"Costa","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I- and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-2105-7-131","article-title":"EpiJen: a server for multistep T cell epitope prediction","volume":"7","author":"Doytchinova","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/jbm.a.31019","article-title":"Enhanced antigen-specific primary CD4+ and CD8+ responses by co-delivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(d,l-lactic-co-glycolic acid) nanoparticles","volume":"81","author":"Hamdy","year":"2007","journal-title":"J Biomed Mater Res A"},{"key":"B33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bej.2006.02.001","article-title":"Preparation and characterization of a temperature-sensitive sulfobetaine polymer-trypsin conjugate","volume":"30","author":"Yan","year":"2006","journal-title":"Biochem Eng J"},{"key":"B34","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1021\/Bp9701224","article-title":"Conjugation of trypsin by temperature-sensitive polymers containing a carbohydrate moiety: thermal modulation of enzyme activity","volume":"14","author":"Lee","year":"1998","journal-title":"Biotechnol Prog"},{"key":"B35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jconrel.2004.07.025","article-title":"WGA-grafted PLGA-nanospheres: preparation and association with Caco-2 single cells","volume":"99","author":"Weissenb\u00f6ck","year":"2004","journal-title":"J Control Release"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1016\/j.vaccine.2011.04.089","article-title":"Cellular vaccination with bone marrow derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis","volume":"29","author":"Agallou","year":"2011","journal-title":"Vaccine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","article-title":"Gene ontology consortium: going forward","volume":"43","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.vaccine.2008.03.003","article-title":"Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells","volume":"26","author":"Carri\u00f3n","year":"2008","journal-title":"Vaccine"},{"key":"B41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/1756-3305-6-342","article-title":"Genetic diversity and structure in Leishmania infantum populations from southeastern Europe revealed by microsatellite analysis","volume":"6","author":"Gouzelou","year":"2013","journal-title":"Parasit Vectors"},{"key":"B42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12026-012-8295-5","article-title":"Structural and functional distinctiveness of HLA-A2 allelic variants","volume":"53","author":"Chen","year":"2012","journal-title":"Immunol Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s002510000271","article-title":"Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes","volume":"52","author":"Longmate","year":"2001","journal-title":"Immunogenetics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jconrel.2005.10.010","article-title":"Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency","volume":"110","author":"Kazzaz","year":"2006","journal-title":"J Control Release"},{"key":"B46","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0168-3659(01)00218-8","article-title":"PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats","volume":"71","author":"Li","year":"2001","journal-title":"J Control Release"},{"key":"B47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1440-1711.2002.01092.x","article-title":"Immuno-informatics: mining genomes for vaccine components","volume":"80","author":"De Groot","year":"2002","journal-title":"Immunol Cell Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1016\/j.vaccine.2008.05.091","article-title":"Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells","volume":"26","author":"Resende","year":"2008","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.4161\/hv.21881","article-title":"Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines","volume":"8","author":"Elfaki","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/513439","article-title":"HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages","volume":"195","author":"Basu","year":"2007","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1371\/journal.pntd.0001295","article-title":"In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response","volume":"5","author":"Seyed","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"B52","first-page":"27","article-title":"Immunogenicity of MHC class I peptides derived from Leishmania mexicana Gp63 in HLA-A2.1 transgenic (HHDII) and BALB\/C mouse models","volume":"7","author":"Rezvan","year":"2012","journal-title":"Iran J Parasitol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.4049\/jimmunol.179.8.5033","article-title":"CD8+ CTL priming by exact peptide epitopes in incomplete Freund\u2019s adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity","volume":"179","author":"Bijker","year":"2007","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrc2373","article-title":"Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines","volume":"8","author":"Melief","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B55","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4049\/jimmunol.154.3.1273","article-title":"Major differences in transporter associated with antigen presentation (TAP)-dependent translocation of MHC class I-presentable peptides and the effect of flanking sequences","volume":"154","author":"Neisig","year":"1995","journal-title":"J Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.0300-9475.2004.01442.x","article-title":"Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine","volume":"60","author":"Wang","year":"2004","journal-title":"Scand J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: an in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J Theor Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-016-0263-6","article-title":"Designing string-of-beads vaccines with optimal spacers","volume":"8","author":"Schubert","year":"2016","journal-title":"Genome Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0138686","DOI":"10.1371\/journal.pone.0138686","article-title":"Design, immune responses and anti-tumor potential of an HPV16 E6E7 multi-epitope vaccine","volume":"10","author":"de Oliveira","year":"2015","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.4049\/jimmunol.166.9.5366","article-title":"Defined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine","volume":"166","author":"Velders","year":"2001","journal-title":"J Immunol"},{"key":"B61","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.157.8.3242","article-title":"Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes","volume":"157","author":"Bergmann","year":"1996","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/Bf02788751","article-title":"The optimization of helper T lymphocyte (HTL) function in vaccine development","volume":"18","author":"Alexander","year":"1998","journal-title":"Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e85955","DOI":"10.1172\/jci.insight.85955","article-title":"Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondii","volume":"1","author":"El Bissati","year":"2016","journal-title":"JCI Insight"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e0142563","DOI":"10.1371\/journal.pone.0142563","article-title":"Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice","volume":"10","author":"Ghaffari-Nazari","year":"2015","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0014-5793(98)01010-2","article-title":"Decelerated degradation of short peptides by the 20S proteasome","volume":"434","author":"Dolenc","year":"1998","journal-title":"FEBS Lett"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13721-016-0142-5","article-title":"Designing and modeling of complex DNA vaccine based on MOMP of Chlamydia trachomatis: an in silico approach","volume":"6","author":"Farhadi","year":"2017","journal-title":"Netw Model Anal Health Inform Bioinform"},{"key":"B67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.micpath.2011.01.011","article-title":"In silico identification of novel protective VS.G antigens expressed by Trypanosoma brucei and an effort for designing a highly immunogenic DNA vaccine using IL-12 as adjuvant","volume":"51","author":"Akhoon","year":"2011","journal-title":"Microb Pathog"},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNF\u03b1 mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"Margaroni","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"B69","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1002\/eji.200425463","article-title":"A mouse model of human adaptive immune functions: HLA-A2.1-\/HLA-DR1-transgenic H-2 class I-\/class II-knockout mice","volume":"34","author":"Pajot","year":"2004","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1517\/14712598.5.7.919","article-title":"HLA class I transgenic mice: development, utilization and improvement","volume":"5","author":"Pascolo","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/(Sici)1521-4141(199910)29:10<3112:Aid-Immu3112>3.0.Co;2-Q","article-title":"H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies","volume":"29","author":"Firat","year":"1999","journal-title":"Eur J Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13046-016-0444-6","article-title":"Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens","volume":"35","author":"Iranpour","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.addr.2011.05.021","article-title":"Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations","volume":"63","author":"Hamdy","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"B74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jconrel.2004.09.014","article-title":"Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery","volume":"102","author":"Chong","year":"2005","journal-title":"J Control Release"},{"key":"B75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1211\/jpp.58.6.0004","article-title":"Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses","volume":"58","author":"Lutsiak","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/Cji.0b013e31802cf3e3","article-title":"\u201cPathogen-mimicking\u201d nanoparticles for vaccine delivery to dendritic cells","volume":"30","author":"Elamanchili","year":"2007","journal-title":"J Immunother"},{"key":"B77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/B978-0-12-397863-9.00003-1","article-title":"Immunoproteasomes: structure, function, and antigen presentation","volume":"109","author":"Ferrington","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1073\/pnas.0711365105","article-title":"Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation","volume":"105","author":"Callahan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.4049\/jimmunol.1000821","article-title":"Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation","volume":"185","author":"Ichiyanagi","year":"2010","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2009.06.022","article-title":"A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells","volume":"31","author":"Bougn\u00e8res","year":"2009","journal-title":"Immunity"},{"key":"B81","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri2379","article-title":"T-cell activation by dendritic cells in the lymph node: lessons from the movies","volume":"8","author":"Bousso","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.immuni.2012.07.004","article-title":"The RIG-I-like receptor LGP2 controls CD8+ T cell survival and fitness","volume":"37","author":"Suthar","year":"2012","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.4049\/jimmunol.175.7.4627","article-title":"A novel role of CD30\/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells","volume":"175","author":"Nishimura","year":"2005","journal-title":"J Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20041389","article-title":"Coordinate expression and trans presentation of interleukin (IL)-15R\u03b1 and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis","volume":"200","author":"Burkett","year":"2004","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.4049\/jimmunol.173.11.6537","article-title":"Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells","volume":"173","author":"Sandau","year":"2004","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nri1246","article-title":"Dendritic-cell control of pathogen-driven T-cell polarization","volume":"3","author":"Kapsenberg","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/1567201043334597","article-title":"Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery","volume":"1","author":"Diwan","year":"2004","journal-title":"Curr Drug Deliv"},{"key":"B88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/eji.201141846","article-title":"CISH is induced during DC development and regulates DC-mediated CTL activation","volume":"42","author":"Miah","year":"2012","journal-title":"Eur J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.4049\/jimmunol.1501310","article-title":"The Notch ligand DLL4 defines a capability of human dendritic cells in regulating Th1 and Th17 differentiation","volume":"196","author":"Meng","year":"2016","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.bbrc.2010.02.153","article-title":"Oncostatin M induces dendritic cell maturation and Th1 polarization","volume":"394","author":"Jung","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","article-title":"IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells","volume":"120","author":"Vigne","year":"2012","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1745-7580-5-3","article-title":"Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?","volume":"5","author":"Kotturi","year":"2009","journal-title":"Immunome Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0005311","DOI":"10.1371\/journal.pntd.0005311","article-title":"Identification of BALB\/c immune markers correlated with a partial protection to Leishmania infantum after vaccination with a rationally designed multi-epitope cysteine protease a peptide-based nanovaccine","volume":"11","author":"Agallou","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania donovani nucleoside hydrolase (NH36) optimizes cross-protection against Leishmania amazonesis infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2016.12.008","article-title":"A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection","volume":"313","author":"Martins","year":"2017","journal-title":"Cell Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasit Vectors"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:47:15Z","timestamp":1692838035000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,13]]},"references-count":96,"alternative-id":["10.3389\/fimmu.2017.00684"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00684","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,13]]},"article-number":"684"}}